370 related articles for article (PubMed ID: 38673891)
1. Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance.
Steinbuch SC; Lüß AM; Eltrop S; Götte M; Kiesel L
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673891
[TBL] [Abstract][Full Text] [Related]
2. Rare but Still There: A Scoping Review on Endometriosis-Associated Ovarian Cancer.
Livori K; Calleja-Agius J
Discov Med; 2024 Mar; 36(182):467-481. PubMed ID: 38531788
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
[TBL] [Abstract][Full Text] [Related]
5. MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3.
Dong M; Yang P; Hua F
Med Sci Monit; 2015 Mar; 21():915-20. PubMed ID: 25819812
[TBL] [Abstract][Full Text] [Related]
6. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL
Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448
[TBL] [Abstract][Full Text] [Related]
8. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
[TBL] [Abstract][Full Text] [Related]
9. [Is endometriosis a precancerous lesion? Perspectives and clinical implications].
Chene G; Caloone J; Moret S; Le Bail-Carval K; Chabert P; Beaufils E; Mellier G; Lamblin G
Gynecol Obstet Fertil; 2016 Feb; 44(2):106-12. PubMed ID: 26850282
[TBL] [Abstract][Full Text] [Related]
10. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
Munksgaard PS; Blaakaer J
Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
[TBL] [Abstract][Full Text] [Related]
11. Histopathology and ARID1A Expression in Endometriosis- Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction.
Wuyung PE; Rahadiati FB; Tjahjadi H; Salinah S; Kusmardi K; Kodariah R; Wiweko B
Asian Pac J Cancer Prev; 2021 Feb; 22(2):553-558. PubMed ID: 33639673
[TBL] [Abstract][Full Text] [Related]
12. Elevated RON protein expression in endometriosis and disease-associated ovarian cancers.
Xu P; Ding S; Zhu L; Le F; Huang X; Tian Y; Zhang X
Arch Gynecol Obstet; 2017 Mar; 295(3):631-639. PubMed ID: 27888297
[TBL] [Abstract][Full Text] [Related]
13. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer.
Suryawanshi S; Huang X; Elishaev E; Budiu RA; Zhang L; Kim S; Donnellan N; Mantia-Smaldone G; Ma T; Tseng G; Lee T; Mansuria S; Edwards RP; Vlad AM
Clin Cancer Res; 2014 Dec; 20(23):6163-74. PubMed ID: 25294912
[TBL] [Abstract][Full Text] [Related]
14. Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis.
Marí-Alexandre J; Carcelén AP; Agababyan C; Moreno-Manuel A; García-Oms J; Calabuig-Fariñas S; Gilabert-Estellés J
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731537
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer in endometriosis: an update on the clinical and molecular aspects.
Ruderman R; Pavone ME
Minerva Ginecol; 2017 Jun; 69(3):286-294. PubMed ID: 28271698
[TBL] [Abstract][Full Text] [Related]
16. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X
Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression.
Long L; Cao Y; Tang LD
Int J Gynecol Cancer; 2012 May; 22(4):539-45. PubMed ID: 22495744
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
del Carmen MG
Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
[TBL] [Abstract][Full Text] [Related]
19. MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.
Tian X; Xu L; Wang P
Int J Clin Exp Pathol; 2015; 8(5):4933-42. PubMed ID: 26191186
[TBL] [Abstract][Full Text] [Related]
20. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
